Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Targeting catecholaminergic signaling may help treat keloid scars.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Etanercept may cause hair fragility and breakage.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Finasteride reduces hair loss by blocking testosterone's effects on scalp cells.